Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
General Rheumatology
•
Allergy & Immunology
•
Primary Immunodeficiency
Is there any value to IgG subclasses in assessing immune deficiency in a patient with normal IgG levels?
Related Questions
Is there any indication for IVIG in immunocompromised patients with only decreased IgM and/or IgA levels?
How would you approach diagnosis of a patient with recurrent episodes of abdominal pain, severe myalgias, low grade fevers and urticaria?
Can Xolair (omalizumab) be safely used in combination with biologics for patients with rheumatic disease?
How do you approach the use of immunosuppressive therapy in patients with rheumatoid arthritis and underlying immunodeficiency, such as IgA deficiency?
Are there specific conventional DMARDs and/or biologics that are contraindicated in patients with alpha-gal allergy?
How often are you performing CT screening in CVID patients to screen for ILD?
How do you approach adjusting insulin pump settings in patients who have received intra-articular corticosteroid injections?
How do you approach hypogammaglobulinemia in a patient with sarcoidosis?
When screening for malignancy, do you order CT with contrast (or) both with and without contrast?
How should rheumatologists address the impact on patients who are initially diagnosed with SLE based on positive ANA, but later reclassified as having UCTD?
